Literature DB >> 26511390

The pharmacology and toxicology of kratom: from traditional herb to drug of abuse.

Marcus L Warner1, Nellie C Kaufman1, Oliver Grundmann2.   

Abstract

Mitragyna speciosa (Rubiaceae), commonly known as kratom, is a tropical tree with a long history of traditional use in parts of Africa and Southeast Asia. In recent years, kratom has gained popularity for use as a recreational drug across the globe. Relatively new to the illicit market and used in a manner different from its traditional applications, preparations of kratom are touted by many as a safe and legal psychoactive product that improves mood, relieves pain, and may provide benefits in opiate addiction. Available literature was reviewed for M. speciosa via PubMed, Google Scholar, CINAHL, and EBSCO to summarize its traditional uses, phytochemical composition, pharmacology and toxicology of proposed active constituents, and potential for misuse and abuse. Research has demonstrated that both stimulant and sedative dose-dependent effects do exist, but a growing concern for the drug's effects and safety of use has resulted in national and international attention primarily due to an increase in hospital visits and deaths in several countries that are said to have been caused by extracts of the plant. The main active alkaloid substances in kratom, mitragynine and 7-hydroxymitragynine, present with a range of CNS stimulant and depressant effects mediated primarily through monoaminergic and opioid receptors. Recently, Palm Beach County, located in the southeastern corridor of Florida, has considered regulating kratom due to public safety concerns following the death of a young adult. At the local, state, and even federal levels, governments are now being confronted with the task of determining the safety and the possible regulation of kratom extracts. There are currently no standard analytical screening techniques for mitragynine and its metabolites following ingestion limiting its detection to more sophisticated techniques like liquid chromatography-mass spectrometry to determine kratom use. The growing concern of the abuse potential of kratom requires careful evaluation of its benefits and potential toxicities.

Entities:  

Keywords:  Drug abuse; Kratom; Mitragyna speciosa; Psychoactive; Stimulant

Mesh:

Substances:

Year:  2015        PMID: 26511390     DOI: 10.1007/s00414-015-1279-y

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  36 in total

Review 1.  Herbal drugs of abuse: an emerging problem.

Authors:  William H Richardson; Cheryl M Slone; Jill E Michels
Journal:  Emerg Med Clin North Am       Date:  2007-05       Impact factor: 2.264

2.  A drug fatality involving Kratom.

Authors:  Michael F Neerman; Randall E Frost; Janine Deking
Journal:  J Forensic Sci       Date:  2012-10-19       Impact factor: 1.832

3.  Identification of mitragynine and O-desmethyltramadol in Kratom and legal high products sold online.

Authors:  Theresa M Scott; Jillian K Yeakel; Barry K Logan
Journal:  Drug Test Anal       Date:  2014-06-24       Impact factor: 3.345

4.  Alkaloids from Mitragyna speciosa (Korth.).

Authors:  A H Beckett; E J Shellard; J D Phillipson; C M Lee
Journal:  J Pharm Pharmacol       Date:  1965-11       Impact factor: 3.765

5.  Substance use among high-school students in Southern Thailand: trends over 3 years (2002-2004).

Authors:  Sawitri Assanangkornchai; Uraiwan Pattanasattayawong; Nisan Samangsri; Anocha Mukthong
Journal:  Drug Alcohol Depend       Date:  2006-07-11       Impact factor: 4.492

6.  Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.

Authors:  Anika A Philipp; Dirk K Wissenbach; Armin A Weber; Josef Zapp; Hans H Maurer
Journal:  J Mass Spectrom       Date:  2010-10-21       Impact factor: 1.982

Review 7.  Pharmacology of kratom: an emerging botanical agent with stimulant, analgesic and opioid-like effects.

Authors:  Walter C Prozialeck; Jateen K Jivan; Shridhar V Andurkar
Journal:  J Am Osteopath Assoc       Date:  2012-12

8.  Rapid detection by direct analysis in real time-mass spectrometry (DART-MS) of psychoactive plant drugs of abuse: the case of Mitragyna speciosa aka "Kratom".

Authors:  Ashton D Lesiak; Robert B Cody; A John Dane; Rabi A Musah
Journal:  Forensic Sci Int       Date:  2014-07-14       Impact factor: 2.395

9.  Inhibitory effects of kratom leaf extract (Mitragyna speciosa Korth.) on the rat gastrointestinal tract.

Authors:  Somsmorn Chittrakarn; Kitja Sawangjaroen; Supaporn Prasettho; Benjamas Janchawee; Niwat Keawpradub
Journal:  J Ethnopharmacol       Date:  2007-11-28       Impact factor: 4.360

Review 10.  Chemistry and pharmacology of analgesic indole alkaloids from the rubiaceous plant, Mitragyna speciosa.

Authors:  Hiromitsu Takayama
Journal:  Chem Pharm Bull (Tokyo)       Date:  2004-08       Impact factor: 1.645

View more
  35 in total

1.  The Right to Use Kratom from the Psychiatric and Islamic Perspectives.

Authors:  Mohammad Farris Iman Leong Bin Abdullah; Mohd Afifuddin Mohamad; Noor Naemah Abdul Rahman
Journal:  J Relig Health       Date:  2021-04

Review 2.  Poisonous or non-poisonous plants? DNA-based tools and applications for accurate identification.

Authors:  Valerio Mezzasalma; Ioannis Ganopoulos; Andrea Galimberti; Laura Cornara; Emanuele Ferri; Massimo Labra
Journal:  Int J Legal Med       Date:  2016-10-30       Impact factor: 2.686

Review 3.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

4.  Exploration of cytochrome P450 inhibition mediated drug-drug interaction potential of kratom alkaloids.

Authors:  Shyam H Kamble; Abhisheak Sharma; Tamara I King; Erin C Berthold; Francisco León; P Katharina L Meyer; Siva Rama Raju Kanumuri; Lance R McMahon; Christopher R McCurdy; Bonnie A Avery
Journal:  Toxicol Lett       Date:  2019-11-07       Impact factor: 4.372

5.  Novel case of maternal and neonatal kratom dependence and withdrawal.

Authors:  Lindsay Mackay; Ronald Abrahams
Journal:  Can Fam Physician       Date:  2018-02       Impact factor: 3.275

Review 6.  Current regulatory guidelines and resources to support research of dietary supplements in the United States.

Authors:  Regan L Bailey
Journal:  Crit Rev Food Sci Nutr       Date:  2018-11-13       Impact factor: 11.176

Review 7.  Kratom.

Authors:  Mark Sanderson; Adrianna Rowe
Journal:  CMAJ       Date:  2019-10-07       Impact factor: 8.262

8.  Fatal combination of mitragynine and quetiapine - a case report with discussion of a potential herb-drug interaction.

Authors:  Rhome L Hughes
Journal:  Forensic Sci Med Pathol       Date:  2018-11-29       Impact factor: 2.007

9.  Cardiac arrest in a young healthy male patient secondary to kratom ingestion: is this 'legal high' substance more dangerous than initially thought ?

Authors:  Hafez Mohammad Ammar Abdullah; Iqra Haq; Randall Lamfers
Journal:  BMJ Case Rep       Date:  2019-07-19

10.  Characterization and identification of eight designer benzodiazepine metabolites by incubation with human liver microsomes and analysis by a triple quadrupole mass spectrometer.

Authors:  Souleiman El Balkhi; Maxime Chaslot; Nicolas Picard; Sylvain Dulaurent; Martine Delage; Olivier Mathieu; Franck Saint-Marcoux
Journal:  Int J Legal Med       Date:  2017-02-04       Impact factor: 2.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.